Antiplasmodial thiostrepton derivatives: proteasome inhibitors with a dual mode of action.

Causing more than one million deaths annually, tropical malaria is a fundamental threat to human health worldwide. Successful chemotherapeutic treatment is increasingly complicated by frequent drug resistance of the malaria parasites Plasmodium Tsp. To counter this, different antimalaria drugs like quinine, mefloquine, and artemisinine are administered increasingly in combination. In addition, potent lowcost antibiotics such as doxycycline, clindamycin, and azithromycin are often applied. 3] The effectiveness of these inhibitors of bacterial protein biosynthesis against malaria is generally explained by the high similarity shared by 70S bacterial ribosomes and mitochondrial or apicoplast ribosomes from the eukaryotic parasite. Protein translation is then locally inhibited in these organelles. 4] A hallmark of this activity is the late onset of their antiplasmodial action, which typically occurs only four days after infection of the red blood cells. 5] This so-called “delayed death effect” is ascribed to the distribution of defective apicoplasts into daughter merozoites during replication of the erythrocytic parasite. The readily accessible thiostrepton (1) was identified early on as a very potent antibiotic with strong activity against many Gram-positive bacteria. It belongs to the large family of thiopeptide antibiotics, which are highly modified macrocyclic peptide natural products produced by ribosomal peptide biosynthesis. Thiostrepton blocks translation in bacteria by binding tightly to the GTPase-associated center of the 70S ribosome. Studies on the action of 1 in eukaryotic cells reported activity associated with immunomodulation, cancer cell proliferation, and growth inhibition of Plasmodium falciparum. 14] Thiostrepton (1) was proven to suppress protein translation in the apicoplast. 14b,c,15] However, immediate killing of the parasites led to the antimalarial effect, in contrast to the action of other ribosomal inhibitors. A delayed death effect was never observed for 1, but the reasons for these deviating properties of thiostrepton remained unclear. Here, we report on semisynthetic thiostrepton derivatives with enhanced potency against P. falciparum, desribe initial structure–activity patterns, and show that the activity of these compounds is tightly linked to the inhibition of the 20S proteasome. To investigate the antimalarial profile of thiostrepton in detail and to elucidate its potential for possible applications, we needed synthetic access to a series of derivatives. Extending previous studies on thiostrepton semisynthesis, we found that the configurationally labile thiazoline unit of 1–3 (ring C) can be selectively oxidized to the corresponding thiazole (Scheme 1). This modification conferred improved chemical stability to the compounds. We then tested a range of lipophilic and hydrophilic derivatives on the human malaria pathogen P. falciparum. This initial screening suggested that hydrophobic extensions at the dehydroamino acid terminus improved the antiplasmodial properties. A focused collection of candidate compounds was then synthesized based on combinations of tail truncation, oxidation, and addition of lipophilic thiols to the terminal dehydroamino acid (Scheme 1, Table 1). All compounds were obtained in good yield, purified by preparative HPLC, and characterized by NMR spectroscopy, HPLC, and HRMS (see the Supporting Information). Compounds 1–14 were then tested for growth inhibition of P. falciparum. Synchronized ring stages were studied at a parasitemia of 1 %, and parasite viability was monitored by measuring the activity of Plasmodium-specific lactate dehydrogenase (see the Supporting Information). In line with previous reports, 14a] we found that 1 suppressed parasite growth with an IC50 of 10 mm in our assay. No delayed death effect was observed (data not shown). Optimum substituents R* seemed to have medium chain lengths (5 and 14). Longer (6), sterically more-demanding (10, 13), and polar (11) appendages were less effective. The B-ring-opened com[*] S. Schoof, B. Ellinger, S. Baumann, M. Potowski, Prof. Dr. Y. Najajreh, Dr. H.-D. Arndt Technische Universit t Dortmund, Fakult t Chemie Otto-Hahn-Strasse 6, 44221 Dortmund (Germany) and Max-Planck-Institut f r Molekulare Physiologie Otto-Hahn-Strasse 11, 44227 Dortmund (Germany) Fax: (+ 49)231-133-2498 E-mail: hans-dieter.arndt@mpi-dortmund.mpg.de

[1]  H. Arndt,et al.  D-cysteine occurrence in thiostrepton may not necessitate an epimerase. , 2009, Chemical communications.

[2]  P. Alonso,et al.  New medicines to improve control and contribute to the eradication of malaria. , 2009, Nature reviews. Drug discovery.

[3]  H. Arndt,et al.  Thiopeptide antibiotic biosynthesis. , 2009, Angewandte Chemie.

[4]  A. Gartel,et al.  FoxM1 Is a General Target for Proteasome Inhibitors , 2009, PloS one.

[5]  H. Overkleeft,et al.  Chemical Tools To Study the Proteasome , 2009 .

[6]  H. Arndt,et al.  Zur Biosynthese von Thiopeptidantibiotika , 2009 .

[7]  R. Dohmen,et al.  Catalytic mechanism and assembly of the proteasome. , 2009, Chemical reviews.

[8]  S. Baumann,et al.  A Fluorescent Probe for the 70 S‐Ribosomal GTPase‐Associated Center , 2009, Chembiochem : a European journal of chemical biology.

[9]  B. Mordmüller,et al.  Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon , 2008, Malaria Journal.

[10]  B. Moore,et al.  Advances in and applications of proteasome inhibitors. , 2008, Current opinion in chemical biology.

[11]  A. Gartel,et al.  Novel anticancer compounds induce apoptosis in melanoma cells , 2008, Cell cycle.

[12]  P. Rosenthal,et al.  Apicoplast translation, transcription and genome replication: targets for antimalarial antibiotics. , 2008, Trends in parasitology.

[13]  C. Crews,et al.  Proteasome inhibition by fellutamide B induces nerve growth factor synthesis. , 2008, Chemistry & biology.

[14]  Frank Schluenzen,et al.  Translational regulation via L11: molecular switches on the ribosome turned on and off by thiostrepton and micrococcin. , 2008, Molecular cell.

[15]  S. Baumann,et al.  Mapping the binding site of thiopeptide antibiotics by proximity-induced covalent capture. , 2008, Journal of the American Chemical Society.

[16]  D. Kuhn,et al.  Proteasome Inhibitors in Cancer Therapy: Lessons from the First Decade , 2008, Clinical Cancer Research.

[17]  N. Doudican,et al.  Inhibition of mitochondrial protein translation sensitizes melanoma cells to arsenic trioxide cytotoxicity via a reactive oxygen species dependent mechanism , 2008, Cancer Chemotherapy and Pharmacology.

[18]  K. El Bissati,et al.  Antimalarial activity of the anticancer and proteasome inhibitor bortezomib and its analog ZL3B , 2007, BMC clinical pharmacology.

[19]  Rachael A. Hughes,et al.  Von Aminosäuren zu Heteroarenen – Thiopeptid-Antibiotika als heterocyclische Peptide aus der Natur† , 2007 .

[20]  C. Moody,et al.  From amino acids to heteroaromatics--thiopeptide antibiotics, nature's heterocyclic peptides. , 2007, Angewandte Chemie.

[21]  T. Owa,et al.  Splicing factor SF3b as a target of the antitumor natural product pladienolide , 2007, Nature Chemical Biology.

[22]  M. Schlitzer,et al.  Malaria Chemotherapeutics Part I: History of Antimalarial Drug Development, Currently Used Therapeutics, and Drugs in Clinical Development , 2007, ChemMedChem.

[23]  H. Overkleeft,et al.  A cell-permeable inhibitor and activity-based probe for the caspase-like activity of the proteasome. , 2007, Bioorganic & medicinal chemistry letters.

[24]  G. McFadden,et al.  The effects of anti-bacterials on the malaria parasite Plasmodium falciparum. , 2007, Molecular and biochemical parasitology.

[25]  M. Groll,et al.  20S proteasome and its inhibitors: crystallographic knowledge for drug development. , 2007, Chemical reviews.

[26]  H. Schwalbe,et al.  L11 domain rearrangement upon binding to RNA and thiostrepton studied by NMR spectroscopy , 2006, Nucleic acids research.

[27]  C. Gille,et al.  Plasmodia express two threonine-peptidase complexes during asexual development. , 2006, Molecular and biochemical parasitology.

[28]  A. Goldberg,et al.  Importance of the Different Proteolytic Sites of the Proteasome and the Efficacy of Inhibitors Varies with the Protein Substrate* , 2006, Journal of Biological Chemistry.

[29]  M. K. Harper,et al.  A Central Strategy for Converting Natural Products into Fluorescent Probes , 2006, Chembiochem : a European journal of chemical biology.

[30]  Tsutomu Suzuki,et al.  Antibiotic susceptibility of mammalian mitochondrial translation , 2005, FEBS letters.

[31]  M. Ghadiri,et al.  Discovery of a biologically active thiostrepton fragment. , 2005, Journal of the American Chemical Society.

[32]  Sushma Chaubey,et al.  The apicoplast of Plasmodium falciparum is translationally active , 2005, Molecular microbiology.

[33]  V. Heussler,et al.  The proteasome inhibitor MLN-273 blocks exoerythrocytic and erythrocytic development of Plasmodium parasites , 2005, Parasitology.

[34]  H. Ueda,et al.  Suppressive effect of antibiotic siomycin on antibody production. , 2004, The Journal of antibiotics.

[35]  Christopher J. Tonkin,et al.  Tropical infectious diseases: Metabolic maps and functions of the Plasmodium falciparum apicoplast , 2004, Nature Reviews Microbiology.

[36]  A. Goldberg,et al.  The Caspase-like Sites of Proteasomes, Their Substrate Specificity, New Inhibitors and Substrates, and Allosteric Interactions with the Trypsin-like Sites* , 2003, Journal of Biological Chemistry.

[37]  T. W. O'brien Properties of Human Mitochondrial Ribosomes , 2003, IUBMB life.

[38]  C. Crews,et al.  Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro. , 2003, The Journal of clinical investigation.

[39]  R. Tsien,et al.  Creating new fluorescent probes for cell biology , 2002, Nature Reviews Molecular Cell Biology.

[40]  K. Lindsten,et al.  Lack of proteasome active site allostery as revealed by subunit-specific inhibitors. , 2001, Molecular cell.

[41]  F. Tortella,et al.  Proteasome inhibitor PS519 reduces infarction and attenuates leukocyte infiltration in a rat model of focal cerebral ischemia. , 2000, Stroke.

[42]  T. McCutchan,et al.  Effects of interruption of apicoplast function on malaria infection, development, and transmission. , 2000, Molecular and biochemical parasitology.

[43]  C. Crews,et al.  Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[44]  C. Crews,et al.  Eponemycin exerts its antitumor effect through the inhibition of proteasome function. , 1999, Cancer research.

[45]  Satoshi Omura,et al.  Proteasome Inhibitors Block Development ofPlasmodium spp , 1998, Antimicrobial Agents and Chemotherapy.

[46]  D. Draper,et al.  Interaction of thiostrepton with an RNA fragment derived from the plastid-encoded ribosomal RNA of the malaria parasite. , 1997, RNA.

[47]  M. Strath,et al.  Thiostrepton binds to malarial plastid rRNA , 1997, FEBS letters.

[48]  T. McCutchan,et al.  Inhibition of Plasmodium falciparum Protein Synthesis , 1997, The Journal of Biological Chemistry.

[49]  D. Roos,et al.  In vitro assays elucidate peculiar kinetics of clindamycin action against Toxoplasma gondii , 1995, Antimicrobial agents and chemotherapy.

[50]  R. Piper,et al.  Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. , 1993, The American journal of tropical medicine and hygiene.

[51]  M. Makler,et al.  Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia. , 1993, The American journal of tropical medicine and hygiene.

[52]  J. Jensen,et al.  Oxygen- and time-dependent effects of antibiotics and selected mitochondrial inhibitors on Plasmodium falciparum in culture , 1985, Antimicrobial Agents and Chemotherapy.

[53]  E. Wulf,et al.  Fluorescent phallotoxin, a tool for the visualization of cellular actin. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[54]  D. Hodgkin,et al.  The Structure of Thiostrepton , 1970, Nature.

[55]  M. Finland,et al.  In vitro observations on A-8506 (bryamycin). , 1958, Antibiotics & chemotherapy.

[56]  R. Wilson,et al.  The plastid of Plasmodium spp.: a target for inhibitors. , 2005, Current topics in microbiology and immunology.

[57]  J. Adams The proteasome: a suitable antineoplastic target , 2004, Nature Reviews Cancer.

[58]  W. Baumeister,et al.  The 26S proteasome: a molecular machine designed for controlled proteolysis. , 1999, Annual review of biochemistry.

[59]  K Tanaka,et al.  Structure and functions of the 20S and 26S proteasomes. , 1996, Annual review of biochemistry.